Literature DB >> 9689111

Mammalian glycophosphatidylinositol anchor transfer to proteins and posttransfer deacylation.

R Chen1, E I Walter, G Parker, J P Lapurga, J L Millan, Y Ikehara, S Udenfriend, M E Medof.   

Abstract

The glycophosphatidylinositol (GPI) anchors of proteins expressed on human erythrocytes and nucleated cells differ with respect to acylation of an inositol hydroxyl group, a structural feature that modulates their cleavability by PI-specific phospholipase C (PI-PLC). To determine how this GPI anchor modification is regulated, the precursor and protein-associated GPIs in two K562 cell transfectants (ATCC and .48) exhibiting alternatively PI-PLC-sensitive and resistant surface proteins were analyzed and the temporal relationship between GPI protein transfer and acquisition of PI-PLC sensitivity was determined. Nondenaturing PAGE analyses demonstrated that, whereas in .48 transfectants the GPI anchors in decay accelerating factor (DAF) and placental alkaline phosphatase (PLAP) were >95% acylated, in ATCC transfectants, they were 60 and 33% unsubstituted, respectively. In contrast, TLC analyses revealed that putative GPI donors in the two lines were identical and were >/=95% acylated. Studies of de novo DAF biosynthesis in HeLa cells bearing proteins with >90% unacylated anchors showed that within 5 min at 37 degreesC (or at 18 degreesC, which does not permit endoplasmic reticilum exit), >50% of the anchor in nascent 44-kDa proDAF protein exhibited PI-PLC sensitivity. In vitro analyses of the microsomal processing of miniPLAP, a truncated PLAP reporter protein, demonstrated that the anchor donor initially transferred to prominiPLAP was acylated and then progressively was deacylated. These findings indicate that (i) the anchor moiety that initially transfers to nascent proteins is acylated, (ii) inositol acylation in mature surface proteins is regulated via posttransfer deacylation, which in general is cell-specific but also can be protein-dependent, and (iii) deacylation occurs in the endoplasmic reticulum immediately after GPI transfer.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9689111      PMCID: PMC21369          DOI: 10.1073/pnas.95.16.9512

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

1.  Biosynthesis of phosphatidylinositol-glycan (PI-G)-anchored membrane proteins in cell-free systems: PI-G is an obligatory cosubstrate for COOH-terminal processing of nascent proteins.

Authors:  K Kodukula; R Amthauer; D Cines; E T Yeh; L Brink; L J Thomas; S Udenfriend
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Characterization of glycophospholipid intermediate in the biosynthesis of glycophosphatidylinositol anchors accumulating in the Thy-1-negative lymphoma line SIA-b.

Authors:  A Puoti; C Desponds; C Fankhauser; A Conzelmann
Journal:  J Biol Chem       Date:  1991-11-05       Impact factor: 5.157

3.  Atypical mannolipids characterize Thy-1-negative lymphoma mutants.

Authors:  P Lemansky; D K Gupta; S Meyale; G Tucker; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  Characterization of putative glycoinositol phospholipid anchor precursors in mammalian cells. Localization of phosphoethanolamine.

Authors:  S Hirose; G M Prince; D Sevlever; L Ravi; T L Rosenberry; E Ueda; M E Medof
Journal:  J Biol Chem       Date:  1992-08-25       Impact factor: 5.157

5.  Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.

Authors:  W D Ratnoff; J J Knez; G M Prince; H Okada; P J Lachmann; M E Medof
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

6.  Derivation and characterization of glycoinositol-phospholipid anchor-defective human K562 cell clones.

Authors:  S Hirose; R P Mohney; S C Mutka; L Ravi; D R Singleton; G Perry; A M Tartakoff; M E Medof
Journal:  J Biol Chem       Date:  1992-03-15       Impact factor: 5.157

7.  Synthesis of mannosylglucosaminylinositol phospholipids in normal but not paroxysmal nocturnal hemoglobinuria cells.

Authors:  S Hirose; L Ravi; G M Prince; M G Rosenfeld; R Silber; S W Andresen; S V Hazra; M E Medof
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

8.  Anchoring and degradation of glycolipid-anchored membrane proteins by L929 versus by LM-TK- mouse fibroblasts: implications for anchor biosynthesis.

Authors:  N Singh; D Singleton; A M Tartakoff
Journal:  Mol Cell Biol       Date:  1991-05       Impact factor: 4.272

9.  Complexity of ethanolamine phosphate addition in the biosynthesis of glycosylphosphatidylinositol anchors in mammalian cells.

Authors:  T Kamitani; A K Menon; Y Hallaq; C D Warren; E T Yeh
Journal:  J Biol Chem       Date:  1992-12-05       Impact factor: 5.157

10.  Biosynthesis of phosphatidylinositol glycan-anchored membrane proteins. Design of a simple protein substrate to characterize the enzyme that cleaves the COOH-terminal signal peptide.

Authors:  K Kodukula; R Micanovic; L Gerber; M Tamburrini; L Brink; S Udenfriend
Journal:  J Biol Chem       Date:  1991-03-05       Impact factor: 5.157

View more
  24 in total

1.  Specificity of GlcNAc-PI de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors.

Authors:  T K Smith; A Crossman; C N Borissow; M J Paterson; A Dix; J S Brimacombe; M A Ferguson
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

Review 2.  Drug delivery by red blood cells: vascular carriers designed by mother nature.

Authors:  Vladimir R Muzykantov
Journal:  Expert Opin Drug Deliv       Date:  2010-04       Impact factor: 6.648

3.  Sialic Acid within the Glycosylphosphatidylinositol Anchor Targets the Cellular Prion Protein to Synapses.

Authors:  Clive Bate; William Nolan; Harriet McHale-Owen; Alun Williams
Journal:  J Biol Chem       Date:  2016-06-20       Impact factor: 5.157

Review 4.  Heritable disorders in the metabolism of the dolichols: A bridge from sterol biosynthesis to molecular glycosylation.

Authors:  Lynne A Wolfe; Eva Morava; Miao He; Jerry Vockley; K Michael Gibson
Journal:  Am J Med Genet C Semin Med Genet       Date:  2012-10-11       Impact factor: 3.908

5.  The glycosylphosphatidylinositol (GPI) biosynthetic pathway of bloodstream-form Trypanosoma brucei is dependent on the de novo synthesis of inositol.

Authors:  Kirstee L Martin; Terry K Smith
Journal:  Mol Microbiol       Date:  2006-07       Impact factor: 3.501

6.  Analysis of membrane topology and identification of essential residues for the yeast endoplasmic reticulum inositol acyltransferase Gwt1p.

Authors:  Koji Sagane; Mariko Umemura; Kaoru Ogawa-Mitsuhashi; Kappei Tsukahara; Takehiko Yoko-o; Yoshifumi Jigami
Journal:  J Biol Chem       Date:  2011-03-02       Impact factor: 5.157

7.  Endoplasmic reticulum localized PerA is required for cell wall integrity, azole drug resistance, and virulence in Aspergillus fumigatus.

Authors:  Dawoon Chung; Arsa Thammahong; Kelly M Shepardson; Sara J Blosser; Robert A Cramer
Journal:  Mol Microbiol       Date:  2014-05-09       Impact factor: 3.501

8.  PIG-W is critical for inositol acylation but not for flipping of glycosylphosphatidylinositol-anchor.

Authors:  Yoshiko Murakami; Uamporn Siripanyapinyo; Yeongjin Hong; Ji Young Kang; Sonoko Ishihara; Hideki Nakakuma; Yusuke Maeda; Taroh Kinoshita
Journal:  Mol Biol Cell       Date:  2003-06-13       Impact factor: 4.138

Review 9.  MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer.

Authors:  Anjum Sohail; Qing Sun; Huiren Zhao; M Margarida Bernardo; Jin-Ah Cho; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2008-06       Impact factor: 9.264

Review 10.  Delivery of drugs bound to erythrocytes: new avenues for an old intravascular carrier.

Authors:  Carlos H Villa; Daniel C Pan; Sergei Zaitsev; Douglas B Cines; Donald L Siegel; Vladimir R Muzykantov
Journal:  Ther Deliv       Date:  2015-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.